CA2719070A1 - Piperidines substituees a titre de composes therapeutiques - Google Patents

Piperidines substituees a titre de composes therapeutiques Download PDF

Info

Publication number
CA2719070A1
CA2719070A1 CA2719070A CA2719070A CA2719070A1 CA 2719070 A1 CA2719070 A1 CA 2719070A1 CA 2719070 A CA2719070 A CA 2719070A CA 2719070 A CA2719070 A CA 2719070A CA 2719070 A1 CA2719070 A1 CA 2719070A1
Authority
CA
Canada
Prior art keywords
straight
chain
methyl
acid
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2719070A
Other languages
English (en)
Inventor
Peter Herold
Robert Mah
Stefan Stutz
Vincenzo Tschinke
Aleksandar Stojanovic
Dirk Behnke
Stjepan Jelakovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CA2719070A1 publication Critical patent/CA2719070A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA2719070A 2008-04-02 2009-04-01 Piperidines substituees a titre de composes therapeutiques Abandoned CA2719070A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08153929.8 2008-04-02
EP08153929 2008-04-02
PCT/EP2009/053898 WO2009121914A1 (fr) 2008-04-02 2009-04-01 Pipéridines substituées à titre de composés thérapeutiques

Publications (1)

Publication Number Publication Date
CA2719070A1 true CA2719070A1 (fr) 2009-10-08

Family

ID=40627638

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2719070A Abandoned CA2719070A1 (fr) 2008-04-02 2009-04-01 Piperidines substituees a titre de composes therapeutiques

Country Status (10)

Country Link
EP (1) EP2271644A1 (fr)
JP (1) JP2011516453A (fr)
KR (1) KR20110002459A (fr)
CN (1) CN101970431A (fr)
AU (1) AU2009232012A1 (fr)
BR (1) BRPI0910991A2 (fr)
CA (1) CA2719070A1 (fr)
EA (1) EA201001517A1 (fr)
MX (1) MX2010010876A (fr)
WO (1) WO2009121914A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011057160A2 (fr) * 2009-11-06 2011-05-12 The Regents Of The Uiversity Of California Procédé permettant d'améliorer l'immunogénicité des antigènes vaccinaux par modification des sites de clivage dans la gp120 du vih-1
MX2012004377A (es) 2009-10-14 2012-06-01 Merck Sharp & Dohme Piperidinas sustituidas que aumentan la actividad de p53 y sus usos.
GB201008209D0 (en) * 2010-05-17 2010-06-30 Senexis Ltd Compounds
WO2013062923A1 (fr) 2011-10-28 2013-05-02 Merck Sharp & Dohme Corp. Macrocycles augmentant l'activité p53 et leurs utilisations
AR094116A1 (es) 2012-12-20 2015-07-08 Merck Sharp & Dohme Imidazopiridinas sustituidas como inhibidores de hdm2
CN105001300A (zh) * 2014-04-17 2015-10-28 复旦大学 组织蛋白酶d抑制剂及其制备方法、药物组合物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1816122A3 (fr) * 2006-01-19 2007-09-19 Speedel Experimenta AG Pipéridines substituées 3,4,5 en tant que composants thérapeutiques
EP1908761A1 (fr) * 2006-10-04 2008-04-09 Speedel Experimenta AG Composés organiques
EP1911758A1 (fr) * 2006-10-04 2008-04-16 Speedel Experimenta AG Derivés de phenyl-piperidine comme inhibiteurs de renin

Also Published As

Publication number Publication date
CN101970431A (zh) 2011-02-09
MX2010010876A (es) 2010-10-26
BRPI0910991A2 (pt) 2016-01-19
EA201001517A1 (ru) 2011-04-29
WO2009121914A1 (fr) 2009-10-08
JP2011516453A (ja) 2011-05-26
KR20110002459A (ko) 2011-01-07
AU2009232012A1 (en) 2009-10-08
EP2271644A1 (fr) 2011-01-12

Similar Documents

Publication Publication Date Title
US20070066582A1 (en) Diaminoalcohols as therapeutic compounds
US20070021413A1 (en) Diamino alcohols as therapeutic compounds
JP7319395B2 (ja) Ｓａｒｍ１の阻害剤
CA2719070A1 (fr) Piperidines substituees a titre de composes therapeutiques
US8153658B2 (en) Piperidine derivative or salt thereof
US20070167433A1 (en) 3,4,5-Substituted piperidines as therapeutic compounds
JP7490781B2 (ja) Ｓａｒｍ１の阻害剤
AU2021333558B2 (en) Inhibitors of SARM1
JP7477642B2 (ja) Ｓａｒｍ１の阻害剤
CA3123215A1 (fr) Inhibiteurs de sarm1 en combinaison avec des agents neuroprotecteurs
US20240051939A1 (en) Benzopyrazole inhibitors of sarm1
EP1958666A1 (fr) Alcanamides substitués hétérocycliques en tant que composants thérapeutiques
US20070021400A1 (en) Amino alcohols as therapeutic compounds
WO2009106599A2 (fr) Pipéridines substituées en tant que composés thérapeutiques
EP1867329A2 (fr) 5-amino-4-hydroxy-2-isopropyl-7-[4-méthoxy-3-(3-méthoxypropoxy)benzyl]-8-méthylnonanamides en tant que composés thérapeutiques
US20070021399A1 (en) Amido-amino alcohols as therapeutic compounds
JP7534390B2 (ja) Ｓａｒｍ１の阻害剤
EP1987834A2 (fr) Pipéridines substituées en tant que composants thérapeutiques
US20070066604A1 (en) Diaminoalcohols as therapeutic compounds
EP1872780A2 (fr) Omega-phényloctanamides en tant que composés thérapeutiques
EP1958634A2 (fr) Pipéridines substituées en tant que inhibiteurs de la sécrétase beta, cathepsine D, plasmepsin II et/ou protéase du VIH
EP2018862A1 (fr) Pipéridines substituées en tant que composants thérapeutiques

Legal Events

Date Code Title Description
FZDE Dead